Kayentis

Kayentis

Pharmaceutical Manufacturing

Meylan, Auvergne-Rhone-Alpes 6,923 followers

Simplify your clinical trial experience

About us

Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company has conducted digital data collection for over 300 clinical trials in 90 countries (100,000 patients), employing 120 languages. It has offices in the US (Boston), France (Grenoble) and Japan (Tokyo), and currently employs 185 staff.

Website
https://kayentis.com/resources
Industry
Pharmaceutical Manufacturing
Company size
51-200 employees
Headquarters
Meylan, Auvergne-Rhone-Alpes
Type
Privately Held
Founded
2003
Specialties
eCOA solutions, Patient engagement, Electronic Clinical Outcome Assessments, Clinical Trials, ePRO, ClinRO, ObsRO, PerfO, eDiary, PRO, DCT solutions, BYOD, and Televisit

Locations

  • Primary

    19 bis, Chemin du Vieux Chêne

    Meylan, Auvergne-Rhone-Alpes 38240, FR

    Get directions
  • 186 South St

    Suite 600

    Boston, Massachusetts 02111, US

    Get directions

Employees at Kayentis

Updates

Similar pages

Browse jobs

Funding